1165P Modelling long-term survival outcomes in patients with stage (stg) IB–IIIA EGFR-mutated NSCLC from the ADAURA trial
Autor: | Cheema, P.K., Heeg, B., Dyer, M., Wu, Y-L., John, T., Shepherd, F.A., de Marinis, F., Melosky, B., Samson, B., Moldaver, D., Shaw, S., Miranda, M., Verhoek, A. |
---|---|
Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S936-S937 |
Databáze: | ScienceDirect |
Externí odkaz: |